Articles from HoloMD

Banyan Treatment Centers, a national provider of substance use disorder and co-occurring mental health treatment services, and HoloMD, a platform enabling Continuous Precision Psychiatry through Human+AI monitoring and reporting, today announced results from a 90-day pilot of the Banyan Companion™ at Banyan Treatment Centers Texas.

HoloMD, the AI-powered Remote Therapeutic Monitoring (RTM) platform for psychiatry, today announced a partnership with Banyan Texas Treatment Center. Banyan Treatment Centers is one of the largest addiction and behavioral health networks in the United States, treating over 17,000 patients per year. As a leading provider of inpatient addiction and mental health services, it has partnered with HoloMD in an effort to improve recovery outcomes and extend AI-powered behavioral health support into treatment-center settings at the time of client discharge, when clients are particularly vulnerable. The collaboration marks HoloMD’s first treatment-center partnership, expanding the reach of its human-supervised AI platform into the recovery care continuum.

HoloMD, the AI-powered Remote Therapeutic Monitoring (RTM) platform for psychiatry, has completed a $1.6 million first close of its $3 million seed round. The company will host a virtual investor presentation on Tuesday, November 11, at 12:00 p.m. ET, to share progress and next-stage growth plans. Interested investors may RSVP to Dominic Fabrizio at Dominic@HoloMD.ai.

HoloMD, the AI-powered remote therapeutic monitoring (RTM) platform for psychiatry, today announced the appointment of veteran med-tech operator Jim Pearson as Executive Chairman, reuniting him with longtime collaborator Joseph (“Joe”) Mark, a Director on HoloMD’s Board. This marks the pair’s third partnership building category-defining healthcare companies that have delivered strong investor returns—following successful outcomes at Suros Surgical Systems and NICO Corporation.